<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48921">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469350</url>
  </required_header>
  <id_info>
    <org_study_id>C15-12</org_study_id>
    <secondary_id>RCB</secondary_id>
    <nct_id>NCT02469350</nct_id>
  </id_info>
  <brief_title>Serious Game for Parkinson's Disease Patients</brief_title>
  <acronym>PARKGAME</acronym>
  <official_title>Feasibility and Acceptability Study of Serious Game Rehabilitation Program in Parkinson's Disease Patients With Resistant Gait and Balance Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators aim to assess the feasibility and acceptability of a serious
      game to rehabilitate gait and balance disorders in 10 patients with Parkinson's disease
      previously operated for deep brain stimulation of the sub thalamic nucleus.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility questionnaire</measure>
    <time_frame>once a week</time_frame>
    <description>self-assessment questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acceptability questionnaire</measure>
    <time_frame>once a week</time_frame>
    <description>self-assessment questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biomechanical parameters of gait and balance</measure>
    <time_frame>at inclusion, 3 weeks, 6 weeks and 18 weeks</time_frame>
    <description>recordings of centres of foot and mass displacements and velocities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>kinematics parameters of gait and balance</measure>
    <time_frame>at inclusion, 3 weeks, 6 weeks and 18 weeks</time_frame>
    <description>range of motion of hip, knee and ankle angles</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Rehabilitation with serious game</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>18 rehabilitation sessions with serious game during a 6-8 weeks period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serious game</intervention_name>
    <description>Rehabilitation with serious game</description>
    <arm_group_label>Rehabilitation with serious game</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Parkinson's disease

          -  Gait and balance disorders

          -  Chronic bilateral deep brain stimulation of the subthalamic nucleus (&gt; 1 year).

        Exclusion Criteria:

          -  Dementia

          -  Ongoing severe medical condition that prevented assessments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Laure Welter, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GHPS, APHP, Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ICM, CIC Neurosciences</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>February 24, 2017</lastchanged_date>
  <firstreceived_date>May 28, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gait and balance disorders</keyword>
  <keyword>serious game</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
